Key result
A structured pre-admission perioperative diabetes management plan significantly increased the appropriate use of diabetes medications from 30% to 71% compared to standard care.
Why the study?
Perioperative diabetes management has become increasingly complex and is often inconsistent, resulting in dysglycaemia and associated morbidity.
Does a structured pre-admission perioperative diabetes management plan improve appropriate diabetes medication use and glycaemia in people with diabetes undergoing elective non-cardiac surgery?
Observational (n=264)
Open-label
No
Does a structured pre-admission perioperative diabetes management plan improve appropriate diabetes medication use and glycaemia in people with diabetes undergoing elective non-cardiac surgery?
Absolute Event Rate: 71% vs 30%
p-value: p=<0.001
A structured perioperative diabetes management plan significantly improves appropriate medication use and glycemic control in patients undergoing elective non-cardiac surgery.
May support structured perioperative diabetes plans in elective surgery; hypothesis-generating pending randomized confirmation.
BACKGROUND: Perioperative diabetes management has become increasingly complex; management is often inconsistent resulting in dysglycaemia and associated morbidity. AIM: To evaluate a structured pre-admission perioperative diabetes management plan (PDMP) for safe and appropriate recommendation, prescription and administration of diabetes medications in the perioperative period for people with diabetes undergoing elective, non-cardiac surgery. METHODS: A multidisciplinary team developed the intervention, a structured PDMP (including diabetes medication reconciliation, management guide, individualised plan) to standardise optimal perioperative diabetes management. A single centre prospective pre- and post-intervention pilot study was performed, including all individuals with diabetes medications attending the pre-admissions clinic during two 4-month periods (February to May) in 2016 (control period) and 2017 (intervention period). The primary outcome was appropriate recommendation, prescription and administration of diabetes medications (including insulin), according to the PDMP, in the perioperative period. Secondary outcomes measures were glycaemia. Analysis was by intention to treat. RESULTS: Control and intervention groups included 131 and 133 participants, respectively; they were well matched in clinical characteristics. The PDMP was completed correctly in 100 (75%) individuals in the intervention group. The appropriate use of diabetes medications increased from 30% in the control group to 71% in the intervention group (p < 0.001). Following the PDMP implementations, glycaemia improved in the overall perioperative period (8.7 ± 2.9 vs. 9.8 ± 3.3 mmol/L, p = 0.005) and at all time points (from admission and over entire hospital stay). CONCLUSION: A structured pre-admission perioperative diabetes management plan for elective surgery improved safe and appropriate diabetes medication use and glycaemia in the perioperative period.
No takes yet. Share an insight, caveat, or question.
Qi et al. (2022) conducted an observational in Diabetes undergoing elective, non-cardiac surgery (n=264). Structured pre-admission perioperative diabetes management plan (PDMP) vs. Standard care was evaluated on Appropriate recommendation, prescription and administration of diabetes medications (p=<0.001). A structured pre-admission perioperative diabetes management plan significantly increased the appropriate use of diabetes medications from 30% to 71% compared to standard care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: